POLYPHARMA
ActiveSummary
POLYPHARMA has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20,154 and a net result of -€8,671. Equity is shrinking by ~5% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.5% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 28 days late
2025
31-12
Financial
Weakest financial yearnet -€8,671
Net result drops to -€8,671, the lowest in the series.
31-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 31 days late
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-12
Financial
Liquidity times 9current ratio 69.52
Current ratio from 7.94 to 69.52; short-term debt falls from €7,190 to €668.
16-11
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 108 days late
2021
31-12
Financial
Liquidity doublescurrent ratio 7.94
Current ratio from 3.75 to 7.94; short-term debt falls from €17,393 to €7,190.
29-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 29 days late
2020
31-12
Financial
Liquidity times 141current ratio 3.75
Current ratio from 0.03 to 3.75; short-term debt falls from €82,183 to €17,393.
22-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 53 days late
2019
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
27-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.